Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) had Return on Investments of -11.71% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$2.06M |
|
$-1.45M |
|
$0.19M |
|
$1.87M |
|
$3.70M |
|
$-1.65M |
|
$0.20M |
|
$-1.45M |
|
$-1.45M |
|
$-1.45M |
|
$-1.45M |
|
$-1.45M |
|
$-1.45M |
|
$-1.65M |
|
$-1.40M |
|
11.46M |
|
11.46M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$12.09M |
|
$2.07M |
|
$5.12M |
|
$17.21M |
|
$2.70M |
|
-- |
|
$2.11M |
|
$4.81M |
|
$12.40M |
|
$12.28M |
|
$12.40M |
|
11.46M |
|
| Cash Flow Statement Financials | |
$-1.17M |
|
$-0.01M |
|
-- |
|
$11.91M |
|
$10.73M |
|
$-1.17M |
|
$0.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
90.85% |
|
-80.19% |
|
-80.19% |
|
-- |
|
-70.66% |
|
-70.66% |
|
$-1.18M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.28 |
|
4.67 |
|
19.27 |
|
-11.71% |
|
-11.82% |
|
-8.44% |
|
|
Return on Investments |
-11.71% |
$1.08 |
|
$-0.10 |
|
$-0.10 |
|